Cargando…
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
Autores principales: | Aydillo, Teresa, Gonzalez-Reiche, Ana S., Aslam, Sadaf, van de Guchte, Adriana, Khan, Zenab, Obla, Ajay, Dutta, Jayeeta, van Bakel, Harm, Aberg, Judith, García-Sastre, Adolfo, Shah, Gunjan, Hohl, Tobias, Papanicolaou, Genovefa, Perales, Miguel-Angel, Sepkowitz, Kent, Babady, N. Esther, Kamboj, Mini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722690/ https://www.ncbi.nlm.nih.gov/pubmed/33259154 http://dx.doi.org/10.1056/NEJMc2031670 |
Ejemplares similares
-
Mycobacterium haemophilum Infection after Alemtuzumab Treatment
por: Kamboj, Mini, et al.
Publicado: (2008) -
A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners
por: Neira, Víctor, et al.
Publicado: (2021) -
Evolution of influenza A virus in intensive and free-range swine farms in Spain
por: Encinas, Paloma, et al.
Publicado: (2021) -
Viable virus shedding during SARS-CoV-2 reinfection
por: Letizia, Andrew G, et al.
Publicado: (2021) -
452 Pseudo-Outbreak of Fulminant Toxoplasmosis in Hematopoietic Stem Cell Transplant [HSCT] Recipients
por: Isa, Flonza, et al.
Publicado: (2014)